Two papers address the contribution of DISC1 to neural development and schizophrenia risk in this issue of Neuron. These complementary studies elegantly bridge the gap between genetic and cellular studies of schizophrenia, providing a level of functional validation that is often lacking in the field.
Schizophrenia is a cognitive disorder afflicting more than 1% of adults worldwide. Beginning in early adulthood, patients with schizophrenia develop symptoms that include auditory hallucinations, delusions, loss of linear and logical thinking, disorganized language, and often a blunting of emotion, motivation, and socialization, which is similar to the presentation of autism. The risk of developing schizophrenia is primarily attributable to genetic rather than environmental factors, with a heritability that is thought to exceed 75%. In theory, this high degree of heritability should facilitate the discovery of the primary causes of schizophrenia; in practice, validation of candidate schizophrenia genes has proved elusive.
Schizophrenia literally means ''split mind.'' This is an apt metaphor to describe the divide that has evolved between the schizophrenia genetics and cell biology literature and that is partially attributable to the disparate methods that each discipline employs. For example, genetic association studies find candidate genes by linking disease occurrence to the presence of specific single nucleotide polymorphisms (SNPs), many of which are nonfunctional. Interpreting the physical significance of these results can be perplexing to experimentalists, who are not accustomed to relying on abstract statistical methods. Because it is difficult to bridge this gap, few studies are able to provide a mechanism that plausibly explains how aberrant functioning of the identified gene could lead to the onset of schizophrenia. These pitfall was cleverly surmounted by two innovative studies in this issue of Neuron focusing on the biology of the schizophrenia candidate gene DISC1 (Kang et al., 2011; Singh et al., 2011) .
In 1968, a cytogenetic survey of Scottish juvenile delinquents detected a single boy who carried a balanced translocation from chromosome 11 into the long arm of chromosome 1. Later analysis revealed a major mental illness in roughly half of those family members carrying the t(1;11) translocation, whereas only 1 in 10 cytogenetically normal relatives were so afflicted (St Clair et al., 1990) . Three decades after its initial discovery, it was recognized that this insertion truncates the gene now known as disrupted in schizophrenia 1 (DISC1), a bit of misnomer given that schizophrenia was less prevalent than major mood disorders in the t(1:11) proband (Millar et al., 2000) . This association with schizophrenia was first corroborated through linkages studies of the Finnish population and later by using SNP-haplotype (genome-wide) association studies of Caucasian and Asian cohorts.
DISC1 is a large scaffolding protein (93 kDa) that is widely expressed throughout the fetal and adult brain, most prominently in the human hippocampus. Initially, yeast two-hybrid screens indentified a host of DISC1 binding partners, including MAP1a, GSK-3b, and PDE4, which bind the N-terminal domain; FEZ1, which binds in the region containing the original t(1,11) disruption; and NDEL1 and LIS1, which bind near the C terminus. Moreover, association studies have linked PDE4, FEZ1, and NDEL1 with disease onset, though none have been rigorously validated (reviewed by Chubb et al., 2008) . Given the wide variety of binding partners, it is not surprising that DISC1 mediates a plethora of different biological functions, both in vitro and in vivo. Some examples include regulating neuroblast migration (Duan et al., 2007; Ishizuka et al., 2011) or the proliferation of neural progenitors via an interaction with GSK-3b (Mao et al., 2009; Singh et al., 2010) .
Signaling through GSK-3b is a key step in the canonical Wnt pathway. This family of pathways is essential for proper development of the fetal forebrain-hippocampus and midbrain dopaminergic systems, the brain regions most frequently implicated in the etiology of schizophrenia and bipolar affective disorder. In fact, one of the first transgenic animal models of schizophrenia was the result of knocking out the Wnt transducing protein disheveled (Lijam et al., 1997) . GSK-3b and Wnt signaling also play critical roles in the development and function of neuronal circuits in the adult brain. Over the past decade, numerous studies have appeared in the literature reporting aberrations in Wnt signaling in the brains of schizophrenic patients. However, most of these results have proved difficult to reproduce, with the notable exception of DISC1 modulation of GSK-3b (reviewed in Hur and Zhou, 2010; Inestrosa and Arenas, 2010) .
The present study by Tsai and colleagues (Singh et al., 2011) posed the following questions: Do genetic changes in DISC1 that have been linked to schizophrenia alter canonical Wnt signaling? And if so, how do they affect neuronal development? They addressed these questions by using a highly innovative combination of in vivo and in vitro model systems that span three species (mouse, zebrafish, and human). Their novel experimental approach began by resequencing the exomes of over 700 schizophrenic, bipolar, or control patients. This allowed them to derive a set of common and rare DISC1 variants to explore further. Then they focused on validating the functionality of individual nonsynonymous (i.e., protein-altering) SNPs. Each of these SNPs causes single amino acid changes to DISC1 and include the common missense variants R264Q, L607F, and S704C, as well as the rare variant A83V (reviewed in Chubb et al., 2008) .
By using a standard assay of canonical Wnt signaling, they demonstrated that wild-type DISC1 potentiates canonical Wnt signaling in human and mouse cell lines. However, this potentiation was abrogated by amino acid substitutions near the GSK-3b binding site, but not by a more distal substitution. In sum, these SNPs reduced canonical Wnt signaling by altering DISC1's interaction with GSK-3b. When tested in mice, the SNPs that reduce canonical activity produced a commensurate decrease in neural progenitor cell proliferation and an increase in neuronal fate commitment. This is consistent with studies demonstrating that human neural progenitors require baseline canonical Wnt activity to remain proliferative and undifferentiated (Wexler et al., 2009) .
Another innovative aspect of this study was the authors' ability to validate their findings using human lymphoblast cells lines, derived from patients harboring each of the common SNPs. Specifically, they showed that Wnt stimulation produced less activation of the canonical pathways in lymphoblasts homozygous for the 264QQ polymorphisms, compared to those wild-type cells (i.e., RR264). They also found that Wnt-stimulated signaling was significantly lower in lymphoblasts from bipolar patients, compared to controls. This further supports the hypothesis that lithium's efficacy in treating bipolar disorder stems from its ability to restore adequate Wnt signaling in affected individuals, given that lithium mimics canonical signaling, including in neural adult progenitors (Wexler et al., 2008) . Although these data are intriguing, they must be interpreted cautiously, because lymphoblasts can only partially recapitulate the behavior of neurons. Ideally, these findings will be further validated in patientderived human neurons produced by cellular reprogramming (Brennand et al., 2011) .
The Song and Ming laboratories took a complementary approach to integrating genetic and functional data (Kang et al., 2011) . They examined the postnatal roles of DISC1 interacting with fasciculation and elongation protein zeta-1 (FEZ1) and nudeE-like 1 (NDEL1), both of which regulate neural migration in utero. An important feature of this study was that they investigated the function of DISC1 in the adult brain, because there is a bias toward exclusively studying candidate schizophrenia genes in the context of early brain development. Early brain development probably plays a significant, but poorly understood, role in the onset of schizophrenia later in life (Niwa et al., 2010; Thompson and Levitt, 2010 ). Yet schizophrenia is still a disorder of early adulthood, with clinically defining symptoms rarely occurring before midadolescence or after midlife. Therefore, it is important to understand how candidate genes function in the adult brain, and their analysis of newborn neurons in the adult hippocampus offers an interesting model to begin to address genetic contributions to both aspects of development and adult function.
They found that loss of FEZ1 increased neuronal soma size and increased length of dendrites in newborn neurons in the adult dentate gyrus, reminiscent of the effects of knocking down DISC1. Moreover, the combined loss of both genes synergistically increased dendritic length. In contrast, loss of NDEL1 increased the appearance of ectopic dendrites and led to aberrant somatic positioning. Again, in contrast to FEZ1, knocking down both DISC1 and NDEL1 produced a phenotype similar to NDEL knockdown alone. Specifically, these experiments suggest that DISC1 primarily regulates neuronal migration and dendritic sprouting through an NDEL-dependent process. However, the regulation of dendrite and soma growth occurs through FEZ1-dependent and -independent pathways. This work demonstrates that DISC1 regulates multiple developmental processes in parallel and that these individual processes can be teased apart when using the appropriate model systems.
Given such strong experimental evidence that the interaction between FEZ1-DISC1 regulates neuronal development, it is surprising that FEZ1 shows such a poorly reproducible association with schizophrenia. This could be the result of a truly weak association, or it could be because prior studies were underpowered, two sides of the same coin. However, the authors' critical insight was realizing that the relevant association is not between schizophrenia and FEZ1 polymorphisms, but rather with the FEZ1-DISC1 functional unit. In genetic terms, they hypothesized an epistatic interaction between DISC1 and FEZ1 that segregates with disease. They tested for such an interaction by first selecting four FEZ1 haplotype-tagging SNPs to reduce multiple comparisons. None were associated with a significant risk for schizophrenia, by themselves. However, a significant association was uncovered when they conditioned their analysis on the presence of the common DISC1-S704C polymorphism. Using a much larger patient cohort, they confirmed that their best FEZ1 SNP conditioned on the DISC1-S704C polymorphism remained significantly associated with disease, though the correlation was inverted. This discrepancy can arise for a host of reasons. Because in this case these four tagging SNPs are not functional variants, it may be that the true functional variants occur on different haplotypes in different populations, or this may represent a spurious result. These data, however, are strong and warrant further attempts at replication. Moreover, they suggest the worth of studying epistasis from a pathway perspective. Taken together, these works by Tsai, Ming, and colleagues demonstrate successful strategies for integrating genetic and cell biological studies of schizophrenia, which we expect will become the norm in this field.
